Valdemar Priebe

Here below are the publications (2) participated by Valdemar Priebe along with Eugenio Gaudio (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors

Blood Advances, 25 maggio 2021

2) Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734

Blood Advances, https://ashpublications.org/bloodadvances/article/4/17/4124/463605/Antitumor-activity-of-the-dual-BET-and-CBP-EP300

Facts & figures

Valdemar Priebe has coordinated or participated in 5 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 13 elements tag cloud:

11q24.3 gain (2) diffuse large B-cell lymphoma (DLBCL) (2) ASB2 (1) BCL6 (1) diffuse large B cell lymphoma (1) ETS1 (1) ETS1 Thr38 phosphorylation (1) hematologic tumors (1) histone deacetylase inhibitors (1) MEK/ERK axis (1) NFKB pathway (1) PRDM1 (1) transcription factor FLI1 (1)

Valdemar Priebe has coordinated or participated in 5 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 4 scientific journals:

Blood Advances (2) British Journal of Haematology (1) Cancers (1) Journal of Experimental & Clinical Cancer Research (1)

Valdemar Priebe has coordinated or participated in 5 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 25 co-authors being active in Ticino:

Andrea Rinaldi (5) Francesco Bertoni (5) Emanuele Zucca (4) Luciano Cascione (4) Giulio Sartori (4) Afua Adjeiwaa Mensah (4) Elaine Yee Lin Chung (3) Filippo Spriano (2) Anastasios Stathis (2) Sara Napoli (2) Davide Rossi (2) Eugenio Gaudio (2) Chiara Tarantelli (2) Alberto Jesus Arribas (2) Maurilio Ponzoni (1) Andrea Cavalli (1) Elisa Civanelli (1) Gaetanina Golino (1) Michela Dall’Angelo (1) Jacopo Sgrignani (1) Laura Bernabei (1) Ivo Kwee (1) Emanuela Lovati (1) Chiara Falzarano (1) Claudio Pietra (1)

Valdemar Priebe has coordinated or participated in 5 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 25 most frequently used terms (excluding 32 not relevant terms) are here listed:

V.P. WORD CLOUD lymphoma (3) sustains (2) ets (2) asb (1) fli (1) nf (1) pathway (1) germinal (1) center-derived (1) b-cell (1) antitumor (1) bet (1) cbp (1) ep (1) neo (1) antilymphoma (1) pracinostat (1) sensitivities (1) dlbcl (1) hdac (1) transcriptional (1) cell-like (1) phosphorylation (1) threonine (1) tumour (1)

In the synopsis of the whole 3332 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 197 most frequently used terms (excluding 32 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (299) covid- (186) thyroid (111) pet (109) cardiac (107) prostate (107) sars-cov- (103) hiv (89) atrial (81) breast (81) coronary (79) sclerosis (76) fibrillation (69) lymphoma (68) pandemic (67) bone (54) aortic (52) heart (51) artery (51) stroke (50) liver (47) carcinoma (46) brain (44) antibodies (42) cardiovascular (41) lung (40) mri (39) transcatheter (36) metastatic (35) dna (35) ventricular (35) kidney (34) nodules (34) tumor (33) extracellular (33) virus (33) myocardial (32) knee (31) ultrasound (30) oncology (30) mitral (27) antibody (27) esmo (27) percutaneous (26) f-fdg (26) hepatitis (25) vesicles (25) spinal (25) antiplatelet (24) cervical (24) ischemic (24) osteoarthritis (23) tuberculosis (23) diabetes (23) infarction (23) chemotherapy (23) ovarian (22) sentinel (22) radiotherapy (22) bladder (22) pulmonary (22) sperm (22) ehra (22) endovascular (21) implantation (21) transplantation (21) vaccination (21) renal (21) blood (20) lymph (19) resonance (19) plasma (19) tomography (19) urinary (19) bacterial (19) b-cell (18) monoclonal (18) nuclear (18) tumors (18) pacing (18) fdg (17) colorectal (17) laparoscopic (17) mice (17) implantable (16) autoimmune (16) vaccine (16) transplant (16) coronavirus (16) immunodeficiency (16) radiomics (15) membrane (15) preclinical (15) metabolic (15) metabolism (15) vascular (15) musculoskeletal (15) tricuspid (14) endometrial (14) pneumonia (14) antiretroviral (14) biomarker (14) serum (14) mrna (14) metastasis (14) lymphomas (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) occlusion (13) male (13) behavior (13) muscle (13) interventions (13) legs (13) radiation (13) arterial (13) hemorrhage (13) nerve (13) biomarkers (13) pregnancy (13) lymphocytic (13) medullary (12) malignant (12) platelet-rich (12) hiv- (12) metastases (12) tau (12) iga (12) conference (12) mutations (12) malignancy (12) brugada (12) joint (12) fna (12) grafts (12) ischemia (12) dementia (12) esc (12) radiology (11) baseline (11) gastric (11) intravenous (11) arrhythmia (11) dynamic (11) incontinence (11) burden (11) pi (11) contemporary (11) contrast-enhanced (11) pathways (11) adherence (11) catheter (11) parkinson (11) limb (11) cytology (11) signaling (11) neck (11) mesenchymal (11) senescence (11) lockdown (11) il- (11) administration (10) overview (10) regurgitation (10) depression (10) art (10) idiopathic (10) clonal (10) bayesian (10) checkpoint (10) antithrombotic (10) precision (10) recovery (10) possible (10) prognosis (10) cancers (10) vascularized (10) adapted (10) peptide (10) ecg (10) infectious (10) fixation (10) prolapse (10) pci (10) hip (10) migraine (10) skin (10) prophylaxis (10) follicular (10) igg (10) vitamin (10) epidemiology (10) lipid (10) refractory (10) anesthesia (10)

Il mondo delle startup

Valdemar Priebe has participated - as a whole - in 5 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Eugenio Gaudio

1) Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors

2) Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734

Valdemar Priebe has participated - as a whole - in 5 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Eugenio Gaudio